Company data
Arrowhead Pharmaceuticals, Inc. employees and revenue per employee
ARWR · Biotechnology · $9.04B market cap
Arrowhead Pharmaceuticals, Inc. had 711 employees at the end of fiscal Sep 2025, up 16.7% from a year earlier. Revenue for the year was $829M, up 23258.2% from a year earlier, or $1.17M per employee. Revenue and headcount both grew, and revenue grew faster.
Employees
711
+16.7% YoY
Revenue
$829M
+23258.2% YoY
Revenue / employee
$1.17M
Peer median $602K
Rank in industry
12 of 39
Biotechnology
Headcount against revenue
Both lines start at 100 in the first year we hold, so you can see which one grew faster.
Hover a year for the numbers.
| Year ending | Employees | Revenue | Per employee | Staff YoY | Revenue YoY |
|---|---|---|---|---|---|
| Sep 2025 | 711 | $829M | $1.17M | +16.7% | +23258.2% |
| Sep 2024 | 609 | $3.6M | $6K | +16.0% | -98.5% |
| Sep 2023 | 525 | $241M | $459K | +32.2% | -1.0% |
| Sep 2022 | 397 | $243M | $613K | +20.7% | +75.9% |
| Sep 2021 | 329 | $138M | $420K | +41.8% | +57.2% |
| Sep 2020 | 232 | $88.0M | $379K | +73.1% | -47.9% |
| Sep 2019 | 134 | $169M | $1.26M | +15.5% | +945.7% |
| Sep 2018 | 116 | $16.1M | $139K | +24.7% | -48.6% |
| Sep 2017 | 93 | $31.4M | $338K | -17.7% | +19736.5% |
| Sep 2016 | 113 | $158,333 | $1K | — | — |
Open roles: we have not matched a verified job board for this company yet.
Arrowhead Pharmaceuticals, Inc. against similar companies
The closest industry peers by revenue, from Biotechnology.
| Company | Employees | Revenue | Revenue / employee | Shape |
|---|---|---|---|---|
| BCRX BioCryst Pharmaceuticals, Inc. | 435 | $875M | $2.01M | Leaner |
| TGTX TG Therapeutics, Inc. | 399 | $616M | $1.54M | Efficient growth |
| ARWR Arrowhead Pharmaceuticals, Inc. | 711 | $829M | $1.17M | Efficient growth |
| MDGL Madrigal Pharmaceuticals, Inc. | 915 | $958M | $1.05M | Efficient growth |
| AXSM Axsome Therapeutics, Inc. | 925 | $638M | $690K | Efficient growth |
| IONS Ionis Pharmaceuticals, Inc. | 1,402 | $944M | $673K | Efficient growth |
| TXG 10x Genomics, Inc. | 1,178 | $643M | $546K | Leaner |
| INSM Insmed Incorporated | 1,664 | $606M | $364K | Efficient growth |
| LEGN Legend Biotech Corporation | 2,900 | $1.03B | $355K | Efficient growth |
Questions about Arrowhead Pharmaceuticals, Inc.
- How many employees does Arrowhead Pharmaceuticals, Inc. have?
- Arrowhead Pharmaceuticals, Inc. reported 711 employees for the fiscal year ending Sep 2025, in the annual report it filed on November 25, 2025. That is up 16.7% from a year earlier.
- What is Arrowhead Pharmaceuticals, Inc.'s revenue per employee?
- Arrowhead Pharmaceuticals, Inc. brought in $829M of revenue in fiscal Sep 2025, which is $1.17M per employee. That ranks 12 of 39 companies we track in Biotechnology, where the median is $602K.
- Where do these numbers come from?
- Employee counts and revenue are taken from each company's own annual report (Form 10-K). Open roles are counted from the company's public job board where we have matched one. Companies report headcount once a year, sometimes rounded, so small changes can be noise.
Free game
Think you can pick better than the S&P 500?
Pick 15 stocks, lock them in, and we score them against the index every trading day for ten years. Free, with a public leaderboard.
Enter the challengeMore data
Compare ARWR with the rest of the market
See who earns the most per employee, who is hiring, and who is cutting, across every company we track.
Source: employee counts and revenue as stated in Arrowhead Pharmaceuticals, Inc.'s annual reports (Form 10-K), latest filed November 25, 2025. This is data, not a recommendation to buy or sell ARWR.